JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, V.
Right arrow Articles by Merz, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, V.
Right arrow Articles by Merz, W. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 16, 11765-11770, April 21, 2000


Disulfide Bond Formation Is Not Required for Human Chorionic Gonadotropin Subunit Association
STUDIES WITH DITHIOTHREITOL IN JEG-3 CELLS*

Vinod SinghDagger and Wolfgang E. Merz§

From the Biochemie-Zentrum Heidelberg, University of Heidelberg, Im Neuenheimer Feld 328, 69120 Heidelberg, Germany

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

To study the influence of disulfide bridge formation on the assembly of the subunits of human chorionic gonadotropin in JEG-3 choriocarcinoma cells, dithiothreitol (DTT) was used to create a reducing milieu in the endoplasmic reticulum (ER) in vivo. In the presence of 5 mM DTT during pulse-chase experiments all of the beta -subunit precursors observed in unperturbed cells (pbeta 0, pbeta 1, pbeta 2, and beta *) collapsed into the pbeta 0 form. The reducing milieu of the ER was reoxidized in less than 5 min after removal of DTT from the medium. DTT markedly increased the half-life of the pbeta 0 precursor from 8.8 to 65.2 min. Under reoxidation conditions, the beta -subunit precursors folded back from pbeta 0 in less than 5 min. In unperturbed JEG-3 cells, the alpha -subunit was present in both fully glycosylated and monoglycosylated precursor (pre-alpha ) forms. The attachment of the second N-linked glycan residue of the alpha -subunit was accelerated in the presence of DTT, and consequently pre-alpha -subunit was missing from the DTT-treated cultures. The formation of alpha beta -dimers appeared to be at least partially independent of the oxidation state in the ER. The alpha beta -dimer was present under conditions in which disulfide bridge formation was prevented by exposure to 5 mM DTT before and during the pulse period. This clearly suggests that the human chorionic gonadotropin subunits may acquire association-competent conformations even when no disulfide bridge formation has taken place.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Secretory and membrane glycoproteins of eukaryotic cells are co-translationally translocated into the lumen of the endoplasmic reticulum (ER)1 from where they travel to Golgi complex on the secretory pathway and to other destinations. Recently, it became evident that the transport of proteins out of the ER is limited by a unique "quality control" system that involves recognition and retention of misfolded or misassembled proteins. If further attempts of acquiring the correct folding fail, these proteins may be directed into a degradation pathway (1-4). In the case of oligomeric proteins, the correct formation of disulfide bonds plays an important role in the assembly of secretory and membrane proteins (5-7), which in turn determines stability, intracellular transport, maturation, and function.

The disulfide bonds are generated through oxidation in the ER. The ER lumen is unique among the various compartments in the eukaryotic cells because it provides an oxidizing environment for the disulfide bond formation with the help of the protein disulfide isomerase that promotes the disulfide bond formation (8, 9). Recently, it was demonstrated that the co-translational disulfide bond formation, folding, and oligomerization of proteins within the ER can be reversibly inhibited by the addition of the disulfide bridge disrupting agent dithiothreitol (DTT) to living cells (10-12). Interestingly, upon the removal of DTT, the disulfide bond formation, folding via normal ER folding intermediates, and oligomerization seems to take place (10-17). Moreover, DTT does not inhibit the transport within the secretory pathway (13, 17).

Human chorionic gonadotropin (hCG), a glycoprotein hormone, is composed of two noncovalently linked and glycosylated alpha - and beta -subunits (18). It is synthesized by the trophoblast cells of the placenta as well as by malignant trophoblast cells and tumors of various origins (19-29). Both subunits are transcribed from separate genes and assembled post-translationally in the ER. JEG-3 choriocarcinoma cells not only secrete hCG but also an excess of free alpha - and a minor quantity of beta -subunit (26). The alpha - and beta -subunits are synthesized via precursors. Five beta -subunit intermediates have been characterized (30, 31). These intermediates represent discrete steps in the folding process that are apparently coupled with the formation of individual disulfide bonds (32). The disulfide bond formation seems to take place post-translationally (30). No attempt has yet been made to understand the effect of DTT on the biosynthesis of alpha - and beta -hCG subunits in vivo. Here, we communicate our investigations on the effect of prevention of the disulfide bridge formation in vivo by the use of DTT on the association of the alpha - and beta -subunits. Moreover, we have studied the effect of reduction and reoxidation on the N-glycosylation of the alpha -subunit as well as on the maturation of the beta -subunit.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Culture-- JEG-3 cells (American Type Culture Collection, Manassas, VA) monolayer cultures were maintained in DMEM medium (Sigma), containing 10% (v/v) fetal calf serum (Linaris Corp., Bettingen, Germany). The medium was supplemented with 3.7 g/liter sodium bicarbonate, 100 IU/ml penicillin, and 100 µg/ml streptomycin (Linaris Corp.). Confluent cell monolayers grown in 25-cm2 plastic flasks (Nunc GmbH, Wiesbaden-Biebrich, Germany) were used for pulse labeling and chase experiments.

Radioactive Labeling and Cell Lysate Preparation-- Confluent (<95%) JEG-3 cells grown at 37 °C in DMEM containing 10% (v/v) fetal calf serum were used for the pulse labeling and chase experiments. The cells, kept for 30 min in deficient medium (DMEM lacking cysteine and methionine) were pulse labeled (for time, see "Results") with 100 µCi/ml [35S]Met/Cys mixture (Amersham Pharmacia Biotech) and chased (for time, see "Results") in the DMEM containing 5 mM excess of Met and Cys in the presence or absence of 5 mM DTT (as indicated below). After incubation, the medium was removed, and the cells were chilled on ice and incubated for 5-10 min with ice cold phosphate-buffered saline (10 mM sodium phosphate, pH 7.2, 150 mM NaCl) containing 40 mM N-ethylmaleimide to prevent the rearrangement of -S-S- bonds by a blockade of the free thiol groups. The cells were again washed three times with the ice-cold phosphate-buffered saline and lysed with 50 mM Tris-HCl lysis buffer, pH 7.6, containing 200 mM NaCl, 0.1% (w/v) SDS, 0.5% (w/v) sodium deoxycholate, 1.0% (w/v) Nonidet P-40, 20 mM N-ethylmaleimide, 20 mM EDTA, and 2 mM phenylmethylsulfonyl fluoride. A post-nuclear supernatant (PNS) was prepared by centrifugation of the lysate at 19,900 × g for 5 min (Biofuge 15, Heraeus, Osterode, Germany). To reduce the nonspecific coprecipitation, the PNS was precleared by shaking with protein A Staphylococcus aureus cells (Sigma; 100 µl cell suspension/1500 µl lysate) for 30 min at 4 °C. The S. aureus cells were pelleted for 5 min at 19,900 × g (Biofuge 15), and the supernatant was used for sequential immunoprecipitation by using two different anti-hCG antibodies as given below.

Immunoprecipitation and SDS-PAGE Analysis-- Two different polyclonal antibodies against the hCG subunits were used in immunoprecipitation of cell lysate. The various beta -subunit forms were purified by using an antibody (G10, kindly provided by Dr. E. Bedows, Omaha, NE) that recognizes all forms of free beta  and beta -subunit precursors but does not cross-react with the alpha -subunit (33). The fraction of the alpha -subunit being associated with the beta -subunit in a dimer, however, is coprecipitated with this antibody. After depleting the PNS of the beta -subunit, their precursors, and the alpha beta -dimer, the supernatant of the same PNS was used for subsequent immunoprecipitation with a goat anti-alpha -hCG antibody (34, 35). The immunoprecipitation with each of the antibodies was carried out for 2 h at 4 °C. The immune complexes were collected on the protein A-agarose beads (Roche Molecular Biochemicals) and washed three times with the lysis buffer and once with 20 mM Tris-HCl buffer, pH 6.8. The immune complexes were eluted by the addition of elution buffer (20 mM Tris-HCl, pH 6.8, containing 1% SDS) and heating of the samples for 1 min in a boiling water bath. Subsequently, the samples were centrifuged at 19,900 × g for 15 min, and aliquots of the supernatant were mixed with the equal volume of the nonreducing sample buffer (100 mM Tris-HCl, pH 6.8, containing 4% (w/v) SDS, 0.2% (w/v) bromphenol blue, and 20% (v/v) glycerol) and reducing sample buffer (containing 10% (v/v) 2-mercaptoethanol), respectively. The samples were separated on SDS-PAGE (Mini-Protean II, Bio-Rad). In all gels, the 14C-labeled molecular weight marker (Rainbow, Amersham Pharmacia Biotech) was run together with the samples. It contained myosine (Mr = 220,000), phosphorylase b (Mr = 97, 400), bovine serum albumin (Mr = 66,000), ovalbumin (Mr = 46,000), carbonic anhydrase (Mr = 30,000), trypsin inhibitor Mr = 21,500), lysozyme (Mr = 14,300), aprotinin (Mr = 6,500), insulin chain B (Mr = 3,400), and insulin chain A (Mr = 2,350) as molecular weight markers. Proteins were precipitated by incubation of the polyacrylamide gels in 20% (w/v) trichloroacetic acid. After two washings (20 min each) in dimethyl sulfoxide, the gels were incubated in 22% (w/v) 2,5 diphenyloxazole (dissolved in dimethyl sulfoxide) for 90 min with gentle shaking. After several washings with water, the gels were transferred to Whatman 3MM paper and dried in a gel dryer (Bio-Rad). The gels were exposed at -80 °C to x-ray film (Fuji RX) in the presence of an intensifying screen. The quantitative evaluation of the x-ray films was performed by laser densitometry (2202 Ultro scan, LKB) and computer-supported calculation of the band intensities of the fluorograms, or by the Kodak Digital Science one-dimensional system (Amersham Pharmacia Biotech).

In some experiments, cells treated with 5 mM DTT prior to (5-40 min) as well as during the pulse (15 min) were lysed at the end of the pulse. The lysate was purified as described above, however, using three different monoclonal antibodies (INN-hCG-45, INN-hCG-53, and INN-hCG-55, kindly provided by Dr. P. Berger, Innsbruck, Austria) directed against epitopes that are exposed on hCG but not on the free subunits to assess the immunologic properties of the alpha beta -dimer formed in the presence of DTT.

Separation of alpha beta -Dimers and Free Subunits by Gel Filtration Chromatography-- Three cultures of JEG-3 cells grown in 75-cm2 flasks were treated 45 min in Met/Cys-deficient DMEM medium (Sigma) prior to labeling with 88.3 MBq [35S]Met/Cys per flask for 45 min followed by 45 min of chase. The cells were rinsed five times with ice-cold phosphate-buffered saline containing each of 5 mM Met and Cys. Cell lysis, preparation of the post-nuclear supernatant, and preabsorption with the protein A S. aureus cells was performed as described above. 2 ml of the lysate were applied to a Sephadex G150 column (0.75 × 100 cm) equilibrated with 50 mM Tris-HCl buffer, pH 7.5, containing 0.05% (w/v) SDS, 20 mM EDTA, 10 mM N-ethylmaleimide, 0.02% (w/v) Nonidet-P40, 2 mM phenylmethylsulfonyl fluoride, and 0.1% (w/v) bovine serum albumin. The column was run in a fast protein liquid chromatography system (Amersham Pharmacia Biotech) at a flow rate of 5 ml/h. Fractions of 750 µl were collected, and 20 µl of aliquot of each fraction was counted in a Tricarb 2450 scintillation counter (Canberra Packard, Dreieich, Germany). The pooled fractions (see below) were purified by immunoprecipitation and analyzed by SDS-PAGE as described above except that boiling of the unreduced samples was omitted. The electrophoresis was performed in duplicate. One gel for the preparation of a fluorogram. The other gel was exposed at 4 °C to a x-ray film (Fuji RX). The bands were excised, and the radioactive material was eluted by breaking up the gels in to small pieces with a glass rod and incubation overnight in reducing sample buffer as well as a freezing-thawing cycle. The eluted proteins were analyzed by SDS-PAGE.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Pulse-Chase Kinetics of the hCG Subunits in the Unperturbed JEG-3 Cells-- The pulse-chase kinetics of the hCG-beta -subunit, their intermediates, and the alpha -subunit contained in alpha beta -dimers is shown in Fig. 1. The band pattern is very similar as observed by others in the case of JAR cells (see below). At least four different precursor forms of the mature beta -subunit can be discerned, designated as pbeta 0, pbeta 1, pbeta 2, and beta *. The pbeta 0 form disappeared completely within the first 15 min of chase (Fig. 1A). The pbeta 1 and pbeta 2 forms show higher apparent molecular weights (Mr = 30,300 and 32,600, respectively) than pbeta 0 (Mr = 25,200) in the SDS-PAGE under nonreducing conditions. Upon reduction of the samples prior to electrophoresis, all the beta -subunit intermediates collapse into one band (Fig. 1B) with the same apparent molecular weight as the pbeta 0 band (Mr = 25,200). This suggests that the different electrophoretic mobilities of the precursors under unreduced conditions display differences in the number of disulfide bridges formed. Small amounts of a beta -subunit with an apparent molecular weight of 36,900 (beta *) emerged at a chase time of 30 min. The apparent molecular weight of this precursor form in the SDS-PAGE is almost identical with that of the mature hCG-beta -subunit; however, beta * showed an apparent molecular weight of 26,500 upon reduction.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 1.   Pulse-chase kinetics of hCG subunits in the unperturbed JEG-3 cells. The cells were incubated in a Met/Cys-free medium for 45 min prior to a 15-min pulse with [35S]Met/Cys mixture (100 µCi/ml). Thereafter, the pulse medium was replaced with the chase medium containing 5 mM Cys and Met for the indicated time. For a 0-min chase (lane 2), the pulse labeled cells were immediately chilled on ice and processed for further washing and lysis. The preabsorbed PNS was immunoprecipitated with the anti-beta antibody (G10). The immune complexes, collected on the protein A-agarose were washed, eluted, and separated on SDS-PAGE under nonreducing (A) and reducing (B) conditions. For further details see "Experimental Procedures." In the right panel part of an experiment is shown with a shorter pulse (30 min of Met/Cys-deficient medium, 2-min pulse) and the first chase time point 2 min after the end of the pulse. The intracellular alpha - and beta -subunit forms are indicated. For further details see the text. In lane 1 the bands of carbonic anhydrase (Mr = 30,000) and trypsin inhibitor (Mr = 21,500) are depicted as molecular weight markers. Similar results were obtained in a total of five experiments.

Moreover, the results also indicate that the observed beta -subunit intermediates represent ER forms of the beta -subunit that have not entered into a Golgi compartment where the O-glycan residues are attached. After this has taken place an apparent molecular weight of 37,500 is reached and maintained also in the presence of reducing agents (beta mature). At the end of the pulse period (Fig. 1A, lane 2), a significant fraction of the alpha -subunit was coprecipitated by the anti-beta antibody (G10), indicating that an alpha beta -dimer has already formed. The free alpha -subunit is not precipitated with G10.

Pulse-Chase Kinetics in the Presence of DTT-- Experiments to find out the efficient DTT concentration needed to reduce the disulfide bridges of the hCG subunits in JEG-3 cells were performed in a range of 0.1- 20 mM DTT. A 5 mM concentration of DTT turned out to be completely sufficient to obtain the same picture of the subunit bands in the SDS-PAGE as after complete reduction of the sample with 1.3 M beta -mercaptoethanol prior to electrophoresis (data not shown). We, therefore used a concentration of 5 mM DTT in the subsequent experiments. The cells were pulse labeled in the absence of DTT and subsequently chased in the presence of 5 mM DTT up to 240 min. The pulse labeled cells showed the presence of alpha -subunit (contained in alpha beta -dimers) and beta -subunit intermediates (Fig. 2, lane 2). The pbeta 0 form was the prominent intermediate in the presence of DTT. Within a period of 5 min in the presence of DTT in the chase medium, a distinctly higher intensity of the pbeta 0 form (36.6 ± 13.0% (n = 4) versus 12.8 ± 1.2% (n = 5) in the absence of DTT; intensity of all beta  forms = 100%) was observed. Moreover, the pbeta 1 intermediate was missing in the presence of DTT.


View larger version (54K):
[in this window]
[in a new window]
 
Fig. 2.   Pulse-chase kinetics of hCG subunits in JEG-3 cells in the presence of DTT. The samples were separated with SDS-PAGE under nonreducing (A) and reducing (B) conditions. The cells were pulse labeled under the same conditions as used in Fig. 1. The chase medium contained 5 mM cysteine and methionine and 5 mM DTT. Lane 1, molecular weight markers (the two strong bands represent the molecular weight markers carbonic anhydrase (Mr = 30,000) and trypsin inhibitor (Mr = 21, 500)); lane 2, pulse labeled cells without chase (no DTT). Lanes 3-9 show the chase of the labeled subunits in the presence of 5 mM DTT for the indicated time. In three other experiments similar results were obtained.

Reoxidation of Reduced alpha - and beta -Subunits-- In a further series of experiments, the DTT treatment was performed during the pulse (15 min) and the first 15 min of chase. Fig. 3 shows the results of a representative experiment. The reduced beta -subunit form (pbeta 0) was the only beta  precursor observed as long as DTT was present. Remarkably, an alpha -subunit band was also visible in the anti-beta precipitated samples (lanes 1 and 2), indicating the presence of alpha beta -dimer even under the reducing conditions in vivo. After 5 min of chase in a DTT-free medium, the beta -subunit precursors seemed to be recovered and reoxidized (Fig. 3A, lane 3). The band pattern seems to be the same as observed in the unperturbed cells.


View larger version (79K):
[in this window]
[in a new window]
 
Fig. 3.   Post-translational reduction and reoxidation of hCG subunits. JEG-3 cells were incubated in the Met/Cys-deficient medium in the absence of DTT for 30 min, pulse labeled for 15 min (lane 1), and further incubated in the chase medium for 15 min (lane 2), each in the presence of 5 mM DTT. Thereafter, the DTT containing chase medium was removed and the cells were chased in the absence of DTT for the indicated time (lanes 3-9). The cell lysates were first immunoprecipitated with the anti-beta G10 antibody. The band pattern SDS-PAGE under nonreducing is given in A. After the immune complexes of the beta -subunit forms with the G10 antibody were removed, the supernatants were treated with the polyclonal anti-alpha antibodies to isolate the free alpha -subunit in the samples (B, nonreducing conditions). The alpha -subunit, immunopurified from the culture medium is depicted in section C (SDS-PAGE under reducing conditions). Similar results were obtained in three other experiments of the same experimental design.

The supernatants of the samples preabsorbed with anti-beta antibody (which removes alpha beta -dimers) were immunoprecipitated with an antibody that recognizes free alpha -subunit. No free alpha -subunit could be detected in the presence of DTT (Fig. 3B, lanes 1 and 2). This is due to the fact that the anti-alpha antibody used does not react with the completely reduced alpha -subunit.2 Within 5 min of DTT-free chase, the free alpha -subunit (alpha  not contained in the alpha beta -dimer) had regained a conformation that was recognized by the anti-alpha antibody (Fig. 3B, lane 3). The decrease of the intracellular alpha -subunit concentration in the later chase time (>= 60 min) was due to the export of the free alpha -subunit via the secretory pathway into the culture medium (Fig. 3C). Besides the mature free beta -subunit (beta m), a small amount of a beta -subunit form with a lower apparent molecular weight (beta f) was also secreted from DTT-treated cells (Fig. 3C). It might represent an immature beta - or a degraded beta -subunit.

Association of alpha - and beta -Subunits-- Gel filtration chromatography of the cell lysates of unperturbed JEG-3 cells was used to separate alpha beta -dimers from free subunits (Fig. 4A). The fractions were pooled as indicated and purified by immunoprecipitation as described above. The immune complexes were eluted from the protein A-Sepharose and applied to the SDS-PAGE with and without reduction of the samples (Fig. 4B). In the unreduced samples of the pooled fractions 1 and 2, the immune complexes were visible as a high molecular weight band that did not enter into the separating gel. Moreover two other bands (Mr = 52,200 and Mr = 37,700) were detected in the gel (Fig. 4B, pool 2). After reduction, the alpha - and beta -subunit bands were visible. Whereas the alpha -subunit present in the pool fractions 1 and 2 was coprecipitated with the beta -subunit (as alpha beta -dimer), the bulk of the free alpha -subunit was eluted from the column in the fractions of pool 3 (Fig. 4B, right panel). The inability of the anti-beta antiserum to precipitate the free alpha -subunits is obvious from the Fig. 4B (left panel). This shows clearly that the alpha -subunit eluted in the higher molecular weight fractions of pool 1 and 2 was indeed part of an alpha beta -dimer complex, whereas the free alpha -subunit was eluted later. We cut the individual bands of the unreduced samples from the gel and separated the eluted material again in SDS-PAGE under reducing conditions to in identify the individual components of each band (Fig. 4C). The immune complexes at the top of the gel dissociated into the same subunit band pattern as already seen in Fig. 4B. The band with Mr = 52,000 turned out to represent an alpha beta *-dimer, whereas the Mr = 37,700 band consisted of alpha -pbeta -dimers. In the pool fraction 3, in addition to the free alpha -subunit, a pre-alpha -band (see also below) was also clearly visible (Fig. 4B). In the case of the alpha beta -dimers the pre-alpha -band was missing (Fig. 4B, pool 2).


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 4.   Separation of alpha  contained in alpha beta -dimer and free alpha -subunit by gel filtration. Unperturbed JEG-3 cells were pulse-chase labeled as described under "Experimental Procedures" in detail. 2 ml of cell lysate were applied to a Sephadex G150 column (0.75 × 100 cm). Further details are described above. Fractions of 750 µl were collected, pooled as indicated (A), purified by immunoprecipitation with anti-beta and anti-alpha antibodies, and analyzed in SDS-PAGE under nonreducing and reducing conditions (B). Under less stringent elution conditions, (more rapid elution at low temperature) in the case of the unreduced samples, only the immune complexes at the top of the gels are visible (bands with Mr = 53,000 and 37,000 were missing; data not shown). The bands of the unreduced samples were cut from the gel, eluted by diffusion, reduced, and separated in SDS-PAGE to identify their individual constituents (C). Similar results were obtained in a total of six independent experiments.

Effect of DTT on the N-Glycosylation of the Free alpha -Subunit-- In the free alpha -subunit fraction (after having removed alpha beta -dimers by immunoprecipitation), besides the regular alpha -subunit (Mr = 20, 500), a molecular variant designated as pre-alpha was observed (apparent Mr = 18,300; Fig. 5). It represents an alpha -subunit with only one of the two carbohydrate residues attached to the protein. Both alpha -subunit forms collapsed into one band with a molecular weight of 10,000 after digestion with peptide N-glycanase F (data not shown). Interestingly, the pre-alpha -subunit was missing in the DTT-treated JEG-3 cells (Fig. 5B). This seems to indicate the accelerated linkage of the second N-linked carbohydrate residue of the alpha -subunit when the disulfide bridges are not formed. In the case of N-glycosylation of the beta -subunit a similar process was not observed.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 5.   Facilitated N-glycosylation in the free alpha -subunit fraction in the presence of DTT. JEG-3 cells were pulse labeled for 2 min and chased as indicated in the absence (A) or in the presence of 5 mM DTT during the first 15 min of chase (B). Cell lysate was immunoprecipitated with anti-alpha . Similar results were observed in two experiments.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We have studied the effect of a prevention of the disulfide bridge formation on the subunit association in hCG biosynthesis. This was achieved by shifting the oxidizing into a reducing milieu in the ER by means of DTT. The DTT concentrations used in the present investigation do not influence protein synthesis and translocation along the secretory pathway (36). In the presence of DTT disulfide bridge formation is delayed and reinitiated post-translationally without a loss in efficiency after removal of DTT (11). The hCG contains as much as 11 disulfide bridges (five in the alpha -subunit and six in the beta -subunit). The significance of the sequence of disulfide bridge formation for the folding and the association of the subunits is not yet fully elucidated. In this context the effect of a replacement in the beta -subunit of individual pairs of cysteine by alanine residues was thoroughly studied (32, 41). This methodology is of great value. However, at least theoretically the possibility cannot be excluded that the elimination of single or even more disulfide bridges might have an impact on the conformation of the subunit as well as on the folding and association with the alpha -subunit. Reduction and reoxidation studies of the wild-type subunits in vivo by the use of DTT provides an independent way to study the interdependences between disulfide bridge formation, folding, subunit association, and N-glycosylation. In this publication, we have addressed the question whether disulfide bridge formation is an essential requirement for subunit association. To our knowledge, no experiments have been published carried out to study the in vivo effects of DTT on the hCG subunit folding pattern and subunit association.

Precursors of the beta -Subunit-- In unperturbed JEG-3 cells, the mature hCG-beta -subunit is formed through well defined intermediates that seem to acquire distinct conformations that allow separation in the SDS-PAGE. Obviously these intermediates are defined by the formation of disulfide bridges (Fig. 1). These beta -subunit precursors seem to resemble very closely or are even identical to the pattern observed and extensively studied in JAR cells (31, 37-39) and Chinese hamster ovary cells transfected with hCG subunits (32, 40, 41). We have purified the beta -subunit intermediates with the same antibodies (G10) as used in the literature (30-33, 39). In JAR cells, the following sequence of beta -subunit intermediates, leading to a form that combines with the alpha -subunit, was described: pbeta 0 right-arrow pbeta 1early right-arrow pbeta 1late right-arrow pbeta 1early right-arrow pbeta 2free right-arrow pbeta 2combined-early right-arrow pbeta 2combined-late (30-32).

This model implies that the subunit association is achieved when the beta -subunit has attained an association competent form as a result of extensive conformational changes as well as disulfide bridge formation as requirements. Here, we did not intend to study the maturation of the beta -subunit in JEG-3 cells but to follow the DTT-induced changes during reduction and reoxidation. DTT has a marked influence on the half-lives of the subunit precursors. The beta -subunit precursors showed very different stability in the presence of DTT. The pbeta 1 was most sensitive to a reducing environment because it disappeared completely within 2 min of in vivo treatment with DTT but again reappeared within 5 min after a change to DTT-free culture medium (Fig. 3A). In the presence of DTT during the chase, the pbeta 2 disappeared rapidly, whereas it was rather stable in the absence of DTT (Table I). The absence of immunoreactive degradation products and the increase in half-life of pbeta 0 indicate that pbeta 2 is most probably converted into pbeta 0 in the presence of DTT. This implicates that the existing disulfide bridges in pbeta 2 are reduced in vivo by DTT because it was also observed in studies with influenza hemagglutinin (11). This is in contrast to other cases where DTT did not disrupt existing disulfide bridges in rotavirus proteins (42).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Half-lives of disappearance of hCG subunit precursors in JEG-3 cells: influence of in vivo reduction of disulfide bridges with DTT

Precursor Forms of the alpha -Subunit-- In the cell lysates the alpha -subunit could be detected as part of an alpha beta -dimer (coprecipitated with anti-beta antibody G10) and as free alpha -subunit as precipitated by specific anti-alpha antibodies (Fig. 4). The apparent molecular weight of the alpha -subunit was reduction-insensitive. Reduction-sensitive intermediate forms, like in the case of the beta -subunit, were not found with the protocol used. Interestingly, a certain amount of the monoglycosylated alpha -subunit (pre-alpha ) was present in the unperturbed cells, whereas it was missing in the presence of DTT (Fig. 5). There is a distinct connection between N-glycosylation and protein folding (43-47). Extensive investigation have been carried out to characterize the effect of N-glycosylation on the folding of the hCG-beta -subunit. Feng et al. (48) have shown that the N-glycans facilitate the correct disulfide bridge bond pairing. Association of a mutant beta -subunit lacking the N-glycans with the alpha -subunit accelerates the formation of certain disulfide bridges. This was interpreted as a hint on the chaperone-like function of the alpha -subunit for the folding pathway of the beta -subunit (46). The beta -subunit might also act as a chaperone facilitating the N-glycosylation of the alpha -subunit because the pre-alpha -subunit was only present in the free alpha  fraction and was not observed in the alpha beta -dimer fraction (Fig. 4). However, presently we cannot rule out the possibility that only a completely N-glycosylated alpha -subunit is associated with the beta -subunit.

Formation of alpha beta -Dimer-- Our gel filtration experiments clearly show the presence of alpha beta -dimers that were coprecipitated with the specific anti-beta antibody. The free alpha -subunit was not precipitated by this antibody. It is remarkable to note that after a short pulse of 2 min, a distinct amount of alpha beta -dimer has already formed (Fig. 1). Unexpectedly, we found an alpha beta -complex present in JEG-3 cells even if the DTT has already been present during the pulse (Fig. 3) or even if it was added together with the Met/Cys-deficient medium prior to the pulse (not shown).

Based on these results, it seems that DTT acts rapidly and quantitatively so that during the pulse (in the presence of DTT) the subunits remain completely in a reduced form. In vitro translation experiments have indicated that the alpha beta -dimer formation is a late event when all pbeta 0 was already converted into other intermediates. It was shown that the pbeta 2-uncombined intermediate acquires an association competent form giving rise to an alpha pbeta 2 complex after having evolved from pbeta 0 through pbeta 1-early and pbeta 1-late (31, 40, 41, 46). All these intermediate forms are characterized by the sequence of disulfide bridges formed. Moreover, it was demonstrated that no association takes place in Chinese hamster ovary cells transfected with a beta -subunit mutant (Cys100 replaced by alanine). This was interpreted to mean that the formation of individual disulfide bridges is the prerequisite for subunit association (32).

Our experiments clearly suggest that the subunit precursors may acquire an association-competent conformation much earlier to give rise to the alpha beta -dimer in the JEG-3 cells, even if no disulfide bridges have formed. The post-translational formation of the disulfide bridges after removal of DTT seems to yield the same subunit precursors as in the untreated cells. It should be emphasized that the alpha beta dimer formed in the presence of DTT represents an immature form that has not yet expressed typical epitopes of the native hCG. This may be concluded from the fact that this alpha beta -dimer was precipitated by the polyclonal antiserum G10 but not by three different monoclonal antibodies directed against epitopes that are present only on hCG and not on the free subunits (not shown).

Recombination of mature subunits in vitro does not require the addition of reducing agents (49, 50). Association of the subunits in the cell and in the test tube is at least initiated very differently because it begins in vivo from partially folded subunits, whereas in vitro the subunits are completely folded and oxidized. Recombination of mature hCG subunits in vitro proceeds slowly and appears to be more complex than a second order process (51), whereas in vivo association occurs rapidly (31, 51). Several studies have shown that during recombination in vitro, alpha beta -intermediates are rapidly formed and only partially share the physical, biologic, and immunologic properties of the native hormone (52, 53). These intermediates regain the full properties of the hormone in a slower reaction (53-55). This process is also probably responsible for the inability of the alpha beta -dimer formed in the presence of DTT to react with quaternary structure-specific anti-hCG monoclonal antibodies (see above). A detailed study on the folding of the bovine pancreatic trypsin inhibitor revealed that the kinetics of folding are highly dependent on the presence of unstable folding intermediates that are mostly undetectable because of their short half-lives. In the course of folding, disulfide bridges are formed randomly and are later rearranged spontaneously by intramolecular thiol-disulfide exchange (56). This may be the reason for the marked increase in the association rate of hCG subunits in vitro in response to the addition of protein disulfide isomerase (31). In the case of alpha beta -dimerization, the situation is complicated by the presence of cystine knots (57) and the "seat belt" structure that is formed by a 21-amino acid arm of the beta -subunit that "embraces" the alpha -subunit (58, 59). Native hCG can be readily dissociated into its subunits by reduction and alkylation (60), but the usual mode of subunit preparation is by dissociation at low pH in the presence of urea (60, 61). Prevention of disulfide bridge formation in vivo does not interfere with heterodimer formation, as demonstrated above. However, in the cell, association-competent folding states of the reduced subunits (in the presence of DTT) seem to prevail, whereas unfolding of the mature subunits by reduction and alkylation probably results in a random structure that does not allow recombination.

A transient formation of aggregates linked by disulfide bridges, as in the case of vesicular stomatitis virus G-protein (14), was not observed. In the case of the alpha -subunit, the N-linked carbohydrate residues seem to be attached much faster when disulfide bridge formation was prevented by DTT. It was also shown that in the further pathway (trimming of the carbohydrate residues, terminal glycosylation in the Golgi apparatus) the Asn78-linked oligosaccharide of the alpha -subunit is processed much more slowly than the Asn52-linked residue (62). Our experiments seem to indicate that already the attachment of at least one of the two carbohydrates of the alpha -subunit is sterically hindered by the folding of the polypeptide chain. Moreover, this part of glycosylation is possibly facilitated by the presence of the beta -subunit that acts in a chaperone-like fashion.

    ACKNOWLEDGEMENTS

The skillful technical assistance of Jean-Michel Krause is gratefully acknowledged. We are indebted to Dr. Elliot Bedows (Omaha, NE) for providing the G10 antibody and to Dr. Peter Berger (Innsbruck, Austria) for the monoclonal antibodies.

    FOOTNOTES

* This work was supported by Grant Me 545/10-1 from the Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg (to W. E. M.) and a fellowship of the Alexander von Humboldt Foundation, Bonn-Bad Godesberg (to V. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Present address: Hormone Biochemistry Laboratory, Inst. of Self Organizing Systems and Biophysics, North-Eastern Hill University, Permanent Campus, Shillong-793022, Meghalaya, India.

§ To whom correspondence should be addressed: Biochemie-Zentrum Heidelberg, University of Heidelberg, Im Neuenheimer Feld 328, 69120 Heidelberg, Germany. Tel.: 49-6221-544181; Fax: 49-6221-545586; E-mail: wolfgang.merz@urz.uni-heidelberg.de.

2 V. Singh and W. E. Merz, unpublished data.

    ABBREVIATIONS

The abbreviations used are: ER, endoplasmic reticulum; hCG, human chorionic gonadotropin; DTT, dithiothreitol; DMEM, Dulbecco's modified Eagle's medium; PNS, post-nuclear supernatant; PAGE, polyacrylamide gel electrophoresis.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Hurtley, S. M., and Helenius, A. (1989) Annu. Rev. Cell Biol. 5, 277-307[CrossRef]
2. Klausner, R. D. (1989) New. Biol. 1, 3-8[Medline] [Order article via Infotrieve]
3. Gething, M. J., and Sambrook, J. (1992) Nature 355, 33-45[CrossRef][Medline] [Order article via Infotrieve]
4. Hammond, C., and Helenius, A. (1995) Curr. Opin. Cell Biol. 7, 523-529[CrossRef][Medline] [Order article via Infotrieve]
5. Machamer, C. E., Doms, R. W., Bole, D. G., Helenius, A., and Rose, J. K. (1990) J. Biol. Chem. 265, 6879-6883[Abstract/Free Full Text]
6. Voorberg, J., Fontijn, R., Calafat, J., Janssen, H., van-Mourik, J. A., and Pannekoek, H. (1991) J. Cell Biol. 113, 195-205[Abstract/Free Full Text]
7. Segal, M. S., Bye, J. M., Sambrook, J. F., and Gething, M. J. (1992) J. Cell Biol. 118, 227-244[Abstract/Free Full Text]
8. Freedman, R. B. (1989) Cell. 57, 1069-1072[CrossRef][Medline] [Order article via Infotrieve]
9. Noiva, R., and Lennarz, W. J. (1992) J. Biol. Chem. 267, 3553-3556[Free Full Text]
10. Braakman, I., Hoover-Litty, H., Wagner, K. R., and Helenius, A. (1991) J. Cell Biol. 114, 401-411[Abstract/Free Full Text]
11. Braakman, I., Helenius, J., and Helenius, A. (1992) EMBO J. 11, 1717-1722[Medline] [Order article via Infotrieve]
12. Braakman, I., Helenius, J., and Helenius, A. (1992) Nature 356, 260-262[CrossRef][Medline] [Order article via Infotrieve]
13. Chanat, E., Weiss, U., Huttner, W. B., and Tooze, S. A. (1993) EMBO J. 12, 2159-2168[Medline] [Order article via Infotrieve]
14. de Silva, A., Braakman, I., and Helenius, A. (1993) J. Cell Biol. 120, 647-655[Abstract/Free Full Text]
15. Lodish, H. F., and Kong, N. (1993) J. Biol. Chem. 268, 20598-20605[Abstract/Free Full Text]
16. Tatu, U., Braakman, I., and Helenius, A. (1993) EMBO J. 12, 2151-2157[Medline] [Order article via Infotrieve]
17. Opstelten, D. J., de Groote, P., Horzinek, M. C., Vennema, H., and Rottier, P. J. (1993) J. Virol. 67, 7394-7401[Abstract/Free Full Text]
18. Pierce, J. G., and Parsons, T. F. (1981) Annu. Rev. Biochem. 50, 465-495[CrossRef][Medline] [Order article via Infotrieve]
19. Pattillo, R. A., and Gey, G. O. (1968) Cancer Res. 28, 1231-1236[Abstract/Free Full Text]
20. Braunstein, G. D., Bridson, W. E., Glass, A., Hull, E. W., and McIntire, K. R. (1972) J. Clin. Endocrinol. Metab. 35, 857-862[Medline] [Order article via Infotrieve]
21. Braunstein, G. D., Vaitukaitis, J. L., Carbone, P. P., and Ross, G. T. (1973) Ann. Intern. Med. 78, 39-45
22. Vaitukaitis, J. L. (1973) J. Clin. Endocrinol. Metab. 37, 505-514[Medline] [Order article via Infotrieve]
23. Vaitukaitis, J. L. (1974) Annu. Clin. Lab. Sci. 4, 276-280
24. Story, M. T., and Hussa, R. O. (1980) J. Clin. Endocrinol. Metab. 50, 1057-1061[Abstract]
25. Hussa, R. O. (1980) Endocr. Rev. 1, 268-294[Medline] [Order article via Infotrieve]
26. Cosgrove, D. E., Campain, J. A., and Cox, G. S. (1989) Biochim. Biophys. Acta 1007, 44-54[Medline] [Order article via Infotrieve]
27. Beastall, G. H., Cook, B., Rustin, G. J., and Jennings, J. (1991) Ann. Clin. Biochem. 28, 5-18
28. Bagshawe, K. D. (1992) Acta Oncol. 31, 99-106[Medline] [Order article via Infotrieve]
29. Hoermann, R., Berger, P., Spoettl, G., Gillesberger, F., Kardana, A., Cole, L. A., and Mann, K. (1994) Clin. Chem. 40, 2306-2312[Abstract/Free Full Text]
30. Huth, J. R., Mountjoy, K., Perini, F., Bedows, E., and Ruddon, R. W. (1992) J. Biol. Chem. 267, 21396-21403[Abstract/Free Full Text]
31. Huth, J. R., Perini, F., Lockridge, O., Bedows, E., and Ruddon, R. W. (1993) J. Biol. Chem. 268, 16472-16482[Abstract/Free Full Text]
32. Bedows, E., Huth, J. R., Suganuma, N., Bartels, C. F., Boime, I., and Ruddon, R. W. (1993) J. Biol. Chem. 268, 11655-11662[Abstract/Free Full Text]
33. Beebe, J. S., Krzesicki, R. F., Norton, S. E., Perini, F., Peters, B. P., and Ruddon, R. W. (1989) Endocrinology 124, 1613-1624[Abstract]
34. Hilf, G., and Merz, W. E. (1989) Biochem. Biophys. Res. Commun. 159, 26-33[CrossRef][Medline] [Order article via Infotrieve]
35. Merz, W. E., Erlewein, C., Licht, P., and Harbarth, P. (1991) J. Clin. Endocrinol. Metab. 73, 84-92[Abstract]
36. Ibrahimi, I. (1987) J. Cell Biol. 105, 1555-1560[Abstract/Free Full Text]
37. Martell, R. E., and Ruddon, R. W. (1990) Endocrinology. 126, 2757-2764[Abstract]
38. Beebe, J. S., Mountjoy, K., Krzesicki, R. F., Perini, F., and Ruddon, R. W. (1990) J. Biol. Chem. 265, 312-317[Abstract/Free Full Text]
39. Huth, J. R., Mountjoy, K., Perini, F., and Ruddon, R. W. (1992) J. Biol. Chem. 267, 8870-8879[Abstract/Free Full Text]
40. Bedows, E., Huth, J. R., and Ruddon, R. W. (1992) J. Biol. Chem. 267, 8880-8886[Abstract/Free Full Text]
41. Bedows, E., Norton, S. E., Huth, J. R., Suganuma, N., Boime, I., and Ruddon, R. W. (1994) J. Biol. Chem. 269, 10574-10580[Abstract/Free Full Text]
42. Svensson, L., Dormitzer, P. R., von Bonsdorff, C. H., Maunula, L., and Greenberg, H. B. (1994) J. Virol. 68, 5204-5215[Abstract/Free Full Text]
43. Helenius, A. (1994) Mol. Biol. Cell 5, 253-265[Medline] [Order article via Infotrieve]
44. Hebert, D. N., Foellmer, B., and Helenius, A. (1995) Cell 81, 425-433[CrossRef][Medline] [Order article via Infotrieve]
45. Feng, W., Bedows, E., Norton, S. E., and Ruddon, R. W. (1996) J. Biol. Chem. 271, 18543-18548[Abstract/Free Full Text]
46. Ruddon, R. W., and Bedows, E. (1997) J. Biol. Chem. 272, 3125-3128[Free Full Text]
47. Leitzgen, K., and Haas, I. G. (1998) Chemtracts 11, 423-445
48. Feng, W., Matzuk, M. M., Mountjoy, K., Bedows, E., Ruddon, R. W., and Boime, I. (1995) J. Biol. Chem. 270, 11851-11859[Abstract/Free Full Text]
49. Morgan, F. J., Canfield, R. E., Vaitukaitis, J. L., and Ross, G. T. (1974) Endocrinology 94, 1601-1606[Medline] [Order article via Infotrieve]
50. Ingham, K. C., Aloj, S. M., and Edelhoch, H. (1974) Arch. Biochem. Biophys. 163, 589-599[CrossRef][Medline] [Order article via Infotrieve]
51. Pierce, J. G., and Parsons, T. F. (1981) Annu. Rev. Biochem. 50, 465-495
52. Merz, W. E., Hilgenfeldt, U., Brockerhoff, P., and Brossmer, R. (1973) Eur. J. Biochem. 35, 297-306[Medline] [Order article via Infotrieve]
53. Bewley, T. A., Sairam, M. R., and Li, C. H. (1974) Arch. Biochem. Biophys. 163, 625-633[CrossRef][Medline] [Order article via Infotrieve]
54. Ingham, K. C., Weintraub, B. D., and Edelhoch, H. (1976) Biochemistry 15, 1720-1726[CrossRef][Medline] [Order article via Infotrieve]
55. Merz, W. E. (1984) in Action of Gonadotropins: Physiology and Clinic (Runnebaum, B. , Rabe, T. , Kiesel, L. , and Merz, W. E., eds) , pp. 59-82, Springer-Verlag, Berlin
56. Creighton, T. E., Darby, N. J., and Kemmink, J. (1996) FASEB J. 10, 110-118[Abstract]
57. Isaacs, N. W. (1995) Curr. Opin. Struct. Biol. 5, 391-395[CrossRef][Medline] [Order article via Infotrieve]
58. Lapthorn, A. J., Harris, D. C., Littlejohn, A., Lustbader, J. W., Canfield, R. E., Machin, K. J., Morgan, F. J., and Isaacs, N. W. (1994) Nature 369, 455-461[CrossRef][Medline] [Order article via Infotrieve]
59. Wu, H., Lustbader, J. W., Liu, Y., Canfield, R. E., and Hendrickson, W. A. (1994) Structure 2, 545-558[Medline] [Order article via Infotrieve]
60. Canfield, R. E., Morgan, F. J., Kammerman, S., Bell, J. J., and Agosto, G. M. (1971) Recent. Prog. Horm. Res. 27, 121-164
61. Swaminathan, N., and Bahl, O. P. (1970) Biochem. Biophys. Res. Commun. 40, 422-427[CrossRef][Medline] [Order article via Infotrieve]
62. Bielinska, M., Matzuk, M. M., and Boime, I. (1989) J. Biol. Chem. 264, 17113-17118[Abstract/Free Full Text]


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.